IsoRay, Inc. (ISR:AMEX) Investor Relations Material

Overview

IsoRay Inc. is a US-based company that specializes in developing, manufacturing, and selling isotope-based medical products and devices. Its primary focus is on cancer treatment and other malignant diseases. IsoRay has made significant advances in utilizing technology to deliver targeted radiation therapy to cancer patients with its groundbreaking Cesium-131 brachytherapy seeds. The company's high-quality products and devices have made it a competitive player in the global medical industry, with its innovative technology being recognized by the medical community worldwide. Overall, IsoRay has established itself as a vital player in the field of cancer treatment, offering patients access to cutting-edge technology that is both effective and affordable.

Frequently Asked Questions

What is IsoRay, Inc.'s ticker?

IsoRay, Inc.'s ticker is ISR

What exchange is IsoRay, Inc. traded on?

The company's shares trade on the AMEX stock exchange

Where are IsoRay, Inc.'s headquarters?

They are based in Richland, Washington

How many employees does IsoRay, Inc. have?

There are 11-50 employees working at IsoRay, Inc.

What is IsoRay, Inc.'s website?

It is http://www.isoray.com/

What type of sector is IsoRay, Inc.?

IsoRay, Inc. is in the Healthcare sector

What type of industry is IsoRay, Inc.?

IsoRay, Inc. is in the Medical Instruments & Supplies industry

Who are IsoRay, Inc.'s peers and competitors?

The following five companies are IsoRay, Inc.'s industry peers:

- Inspecs Group PLC

- BIOLASE

- Insulet

- Repligen

- Inogen